AHA: Mavacamten May Treat Hypertrophic Cardiomyopathy
Improvements in cardiac structure, function seen at 30 weeks of treatment with mavacamten versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.